Products

Below is a list of the treatments we currently offer via our Innovative Medicines Division. 
Please note: Not all treatments are available in all countries.

Product Information

Treatment of patients with HER2 overexpressing breast cancer in combination with: Capecitabine, for treatment of patients with advanced or metastatic breast cancer who have progressed on prior trastuzumab therapy in the metastatic setting, HR+ mets BC.

Active Ingredients - Lapatinib ditosylate monohydrate

Product Division - Novartis Pharmaceuticals